Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M32,295Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M961EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)22.6Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book5.210-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %1.4PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M100,000,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with IWF

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
IWFKen Fisher 2016-12-31 Add$99.72 - $106.61
$ 107.584%Add 38.04%5,498
IWFKen Fisher 2016-09-30 Buy $100.28 - $105.68
$ 107.583%New holding3,983
IWFKen Fisher 2016-06-30 Sold Out $95.95 - $101.8
$ 107.588%Sold Out0
IWFKen Fisher 2016-03-31 Reduce$88.32 - $99.97
$ 107.5814%Reduce -32.43%2,119
IWFKen Fisher 2015-12-31 Buy $94.79 - $102.36
$ 107.588%New holding3,136
IWFKen Fisher 2015-09-30 Sold Out $91.11 - $103.24
$ 107.589%Sold Out0
IWFKen Fisher 2015-06-30 Buy $98.56 - $101.99
$ 107.587%New holding2,605
IWFKen Fisher 2012-03-31 Sold Out -0.0015%$58.63 - $66.45
$ 107.5882%Sold Out0
IWFKen Fisher 2011-12-31 Buy $51.04 - $59.65
$ 107.5889%New holding8,522
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

IWF is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!

IWF: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Rapps, MichaelDirector, Director or Senior Officer of 10% Securi 2017-01-16Buy1,200$9.481034.81view
Gridley, Anthony RonaldSenior Officer 2017-01-16Sell1,800$16.94535.06view
DINWOODIE, TYLER WAYNE PAULSenior Officer 2017-01-16Buy4,000$0.1763182.35view
Brown, Mark ThomasDirector 2017-01-16Sell29,300$1.367810.29view
Bebek, IvanDirector 2017-01-16Buy8,990$3.383082.84view
smith, laurie james10% Security Holder, Director, Senior Officer 2017-01-16Buy7,500$0.4126139.02view
MEHR, JEFFREYSenior Officer 2017-01-13Sell50,000$27.91285.45view
Squibb, Geoffrey WayneDirector 2017-01-13Buy267$6.271615.79view
Smith, DavidSenior Officer 2017-01-13Sell15,000$60.3878.17view
Rowlands, William BruceDirector, Senior Officer 2017-01-13Buy20,000$0.1571620view

Quarterly/Annual Reports about IWF:

    News about IWF:

    Articles On GuruFocus.com
    John Rogers Comments on JLL Jan 20 2017 
    John Rogers Comments on Charles River Laboratories Intl Jan 20 2017 
    John Rogers Comments on Keysight Technologies Jan 20 2017 
    John Rogers Comments on Thermo Fisher Scientific Inc. Jan 20 2017 
    John Rogers Comments on Zimmer Biomet Holdings Jan 20 2017 
    John Rogers Comments on Northern Trust Corp Jan 20 2017 
    John Rogers Comments on Bristow Group Inc. Jan 20 2017 
    Baron Funds Comments on Dominion Midstream Partners Jan 20 2017 
    Baron Funds Comments on Liberty Expedia Holdings Jan 20 2017 
    Baron Funds Comments on Foundation Medicine Jan 20 2017 

    More From Other Websites
    Larry Fink: Markets Have Rallied Quite Considerably Jan 20 2017
    What Does the Rising US Consumer Sentiment Index Mean for the Economy? Jan 17 2017
    Colgate-Palmolive Declares Dividend of $0.39 Per Share Jan 16 2017
    Growth ETF (IWF) Hits New 52-Week High Jan 16 2017
    Will Wage Growth Continue to Support US Economy? Jan 13 2017
    Heresy? These 7 actively managed funds are winners Jan 09 2017
    [$$] How to Pick Great Funds Jan 07 2017
    Combination Therapy Could Boost Vertex Pharmaceuticals’ Revenues Dec 30 2016
    Carl Icahn: Dangerous Amount of Money Blocked in ETFs Dec 29 2016
    US 3Q16 GDP Growth Increased Investor Confidence in the Economy Dec 28 2016
    Nasdaq CEO: Expect Robust Earnings Growth in 2017 Dec 27 2016
    US Consumer Sentiment Index Rose: What It Means for the Economy Dec 27 2016
    Celgene, Evotec Target Unmet Demand in Neurodegenerative Segment Dec 23 2016
    Which Economic Indicators Should Investors Watch This Week? Dec 22 2016
    Opdivo Is a Key Growth Driver for Bristol-Myers Squibb in 2016 Dec 22 2016
    US Retail Sales Showed Weaker Improvement in November Dec 21 2016
    The US Dollar Is Strengthening: How Will It Impact the Economy? Dec 20 2016
    Where Is EW’s SHV Therapy Segment Headed after Disappointing 3Q16 Sales? Dec 19 2016
    The Markets Are Rising: How High-Yield ETFs Could Perform Dec 16 2016
    Edwards Lifesciences Riding High on TAVR Sales Growth and Future Opportunities Dec 16 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)